BPIQ Blog

Aug 7, 20231 min read

SYFOVRE (APLS) vs. IZERVAY (Astellas)

Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...

Jul 31, 20231 min read

Apellis Pharmaceuticals (APLS)

BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...

Jul 24, 20231 min read

How to make $$$ investing in biopharma

Consistent with top 36 biopharma hedge funds • Each held 22-125 companies @ end Q1 ⇒ Stonepine (22 companies) ⇒ EcoR1 (58) ⇒ RA Capital...

Jul 14, 20232 min read

Finally... Therapeutics that slow Alzheimer’s

But, which is the best? • Some anti-beta amyloids (ABs) made it ⇒ thru pos Ph3 ⇒ 1 full FDA approval But lots of ABs have died in...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity